Literature DB >> 30146391

Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination.

Sara B Cohen1, Benjamin H Gern2, Jared L Delahaye3, Kristin N Adams1, Courtney R Plumlee1, Jessica K Winkler1, David R Sherman4, Michael Y Gerner5, Kevin B Urdahl6.   

Abstract

Mycobacterium tuberculosis (Mtb) infection is initiated in the distal airways, but the bacteria ultimately disseminate to the lung interstitium. Although various cell types, including alveolar macrophages (AM), neutrophils, and permissive monocytes, are known to be infected with Mtb, the initially infected cells as well as those that mediate dissemination from the alveoli to the lung interstitium are unknown. In this study, using a murine infection model, we reveal that early, productive Mtb infection occurs almost exclusively within airway-resident AM. Thereafter Mtb-infected, but not uninfected, AM localize to the lung interstitium through mechanisms requiring an intact Mtb ESX-1 secretion system. Relocalization of infected AM precedes Mtb uptake by recruited monocyte-derived macrophages and neutrophils. This dissemination process is driven by non-hematopoietic host MyD88/interleukin-1 receptor inflammasome signaling. Thus, interleukin-1-mediated crosstalk between Mtb-infected AM and non-hematopoietic cells promotes pulmonary Mtb infection by enabling infected cells to disseminate from the alveoli to the lung interstitium.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ESX-1; IL-1; alveolar macrophages; granuloma; innate immunity; lung; pulmonary tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 30146391      PMCID: PMC6152889          DOI: 10.1016/j.chom.2018.08.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  45 in total

1.  Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo.

Authors:  Andrea J Wolf; Beth Linas; Giraldina J Trevejo-Nuñez; Eleanor Kincaid; Toshiki Tamura; Kiyoshi Takatsu; Joel D Ernst
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

2.  Multiplex, quantitative cellular analysis in large tissue volumes with clearing-enhanced 3D microscopy (Ce3D).

Authors:  Weizhe Li; Ronald N Germain; Michael Y Gerner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

3.  Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome.

Authors:  Bibhuti B Mishra; Pedro Moura-Alves; Avinash Sonawane; Nir Hacohen; Gareth Griffiths; Luis F Moita; Elsa Anes
Journal:  Cell Microbiol       Date:  2010-02-09       Impact factor: 3.715

4.  Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo.

Authors:  Katrin D Mayer-Barber; Daniel L Barber; Kevin Shenderov; Sandra D White; Mark S Wilson; Allen Cheever; David Kugler; Sara Hieny; Patricia Caspar; Gabriel Núñez; Dirk Schlueter; Richard A Flavell; Fayyaz S Sutterwala; Alan Sher
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

5.  IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.

Authors:  Pamela Gasse; Caroline Mary; Isabelle Guenon; Nicolas Noulin; Sabine Charron; Silvia Schnyder-Candrian; Bruno Schnyder; Shizuo Akira; Valérie F J Quesniaux; Vincent Lagente; Bernhard Ryffel; Isabelle Couillin
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation.

Authors:  Naeha Subramanian; Kannan Natarajan; Menna R Clatworthy; Ze Wang; Ronald N Germain
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

7.  Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes.

Authors:  Daigo Hashimoto; Andrew Chow; Clara Noizat; Pearline Teo; Mary Beth Beasley; Marylene Leboeuf; Christian D Becker; Peter See; Jeremy Price; Daniel Lucas; Melanie Greter; Arthur Mortha; Scott W Boyer; E Camilla Forsberg; Masato Tanaka; Nico van Rooijen; Adolfo García-Sastre; E Richard Stanley; Florent Ginhoux; Paul S Frenette; Miriam Merad
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

Review 8.  Tuberculosis.

Authors:  Madhukar Pai; Marcel A Behr; David Dowdy; Keertan Dheda; Maziar Divangahi; Catharina C Boehme; Ann Ginsberg; Soumya Swaminathan; Melvin Spigelman; Haileyesus Getahun; Dick Menzies; Mario Raviglione
Journal:  Nat Rev Dis Primers       Date:  2016-10-27       Impact factor: 52.329

9.  Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing.

Authors:  Philana Ling Lin; Christopher B Ford; M Teresa Coleman; Amy J Myers; Richa Gawande; Thomas Ioerger; James Sacchettini; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Med       Date:  2013-12-15       Impact factor: 53.440

10.  Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids.

Authors:  C J Cambier; Kevin K Takaki; Ryan P Larson; Rafael E Hernandez; David M Tobin; Kevin B Urdahl; Christine L Cosma; Lalita Ramakrishnan
Journal:  Nature       Date:  2013-12-15       Impact factor: 49.962

View more
  117 in total

Review 1.  Infect and Inject: How Mycobacterium tuberculosis Exploits Its Major Virulence-Associated Type VII Secretion System, ESX-1.

Authors:  Sangeeta Tiwari; Rosalyn Casey; Celia W Goulding; Suzie Hingley-Wilson; William R Jacobs
Journal:  Microbiol Spectr       Date:  2019-05

Review 2.  Does tissue imprinting restrict macrophage plasticity?

Authors:  Martin Guilliams; Freya R Svedberg
Journal:  Nat Immunol       Date:  2021-01-18       Impact factor: 25.606

Review 3.  Immunometabolism at the interface between macrophages and pathogens.

Authors:  David G Russell; Lu Huang; Brian C VanderVen
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

Review 4.  Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

Authors:  Anca Dorhoi; Leigh A Kotzé; Jay A Berzofsky; Yongjun Sui; Dmitry I Gabrilovich; Ankita Garg; Richard Hafner; Shabaana A Khader; Ulrich E Schaible; Stefan He Kaufmann; Gerhard Walzl; Manfred B Lutz; Robert N Mahon; Suzanne Ostrand-Rosenberg; William Bishai; Nelita du Plessis
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 5.  Mycobacterium tuberculosis: Bacterial Fitness within the Host Macrophage.

Authors:  Lu Huang; Evgeniya V Nazarova; David G Russell
Journal:  Microbiol Spectr       Date:  2019-03

Review 6.  Immunometabolism during Mycobacterium tuberculosis Infection.

Authors:  Nicole C Howard; Shabaana A Khader
Journal:  Trends Microbiol       Date:  2020-05-11       Impact factor: 17.079

7.  Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo.

Authors:  Alissa C Rothchild; Gregory S Olson; Johannes Nemeth; Lynn M Amon; Dat Mai; Elizabeth S Gold; Alan H Diercks; Alan Aderem
Journal:  Sci Immunol       Date:  2019-07-26

8.  Identification of an Increased Alveolar Macrophage Subpopulation in Old Mice That Displays Unique Inflammatory Characteristics and Is Permissive to Mycobacterium tuberculosis Infection.

Authors:  William P Lafuse; Murugesan V S Rajaram; Qian Wu; Juan I Moliva; Jordi B Torrelles; Joanne Turner; Larry S Schlesinger
Journal:  J Immunol       Date:  2019-09-11       Impact factor: 5.422

9.  Mycobacterial Trehalose 6,6'-Dimycolate-Induced M1-Type Inflammation.

Authors:  Thao K T Nguyen; John d'Aigle; Luis Chinea; Zainab Niaz; Robert L Hunter; Shen-An Hwang; Jeffrey K Actor
Journal:  Am J Pathol       Date:  2019-11-14       Impact factor: 4.307

Review 10.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.